Phenolic derivatives from Wigandia urens with weak activity against the chemokine receptor CCR5

Phytochemistry

Volumn 64, Issue 5, 2003, Pages 987-990

  Cao, Shugeng ^a   Rossant, Christine ^a   Ng, Siewbee ^a   Buss, Antony D ^a   Butler, Mark S ^a  

^a MerLion Pharmaceuticals Pte Ltd   (Singapore)

Author keywords

2,3 Dihydroxy 4 methoxy 6,6,9 trimethyl 6H dibenzo b,d pyran; 4 Methoxy 3 (3 methyl 2 butenyl) benzoic acid; 8 Methoxy 2 methyl 2 (4 methyl 3 pentenyl) 2H 1 benzopyran 6 ol; Benzopyran; CCR5; Hydrophyllaceae; Phenolic derivatives; Wigandia urens

Indexed keywords

2,3 DIHYDROXY 4 METHOXY 6,6,9 TRIMETHYL 6H DIBENZO[B,D]PYRAN; 4 METHOXY 3 (3 METHYL 2 BUTENYL)BENZOIC ACID; 8 METHOXY 2 METHYL 2 (4 METHYL 3 PENTENYL) 2H 1 BENZOPYRAN 6 OL; CHEMOKINE RECEPTOR CCR5; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HYDROPHYLLACEAE; SPECTROSCOPY; STRUCTURE ANALYSIS; WIGANDIA URENS;

HYDROPHYLLACEAE; WIGANDIA; WIGANDIA URENS;

EID: 0142026144     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9422(03)00448-5     Document Type: Article

References (13)

1. Berger, E.A., Murphy, P.M., Farber, J.M., 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annual Review of Immunology 17, 657-700.
2. Cook, N.D., 1996. Scintillation proximity assay: a versatile high-throughput screening technology. Drug Discovery Today 1, 287-294.
3. De Clercq, E., 2002. New anti-HIV agents and targets. Med. Res. Rev. 22, 531-535.
4. Folkers, K., Woodruff, H.B., 1963. Methoxynovobiocin. US 3093549; 1963, Chem. Abstr. 59, 4518d.
5. Gonzalez-Zertuche, L., Vazquez-Yanes, C., Gamboa, A., Sanchez-Coronado, M.E., Aguilera, P., Orozco-Segovia, A., 2001. Natural priming of Wigandia urens seeds during burial: Effects on germination, growth and protein expression. Seed Sci. Res. 11, 27-34.
6. Kazmierski, W.M., Boone, L., Lawrence, W., Watson, C., Kenakin, T., 2002. CCR5 chemokine receptors: gatekeepers of HIV-1 infection. Current Drug Targets: Infectious Diseases 2, 265-278.
7. Kedzierska, K., Crowe, S.M., Turville, S., Cunningham, A.L., 2003. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macropharges. Rev. Med. Virology 13, 39-56.
8. Lehner, T., 2002. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Trends in Immunology 23, 531-565.
9. Lusso, P., 2000. Chemokines and viruses: the dearest enemies. Virology 273, 228-240.
10. Mukai, K., Okabe, K., Hosose, H., 1989. Synthesis and stopped-flow investigation of antioxidant activity of tocopherols. Finding of new tocopherol derivatives having the highest antioxidant activity among phenolic antioxidants. J. Org. Chem. 54, 557-560.
11. Pettit, G.R., Kamano, Y., Aoyagi, R., Hearld, C.L., Doubek, D.L., Schmidt, J.M., Rudloe, J.J., 1985. Antineoplastic agents 100. The marine bryozoan Amathia convoluta. Tetrahedron 41, 985-994.
12. Schwarz, M. Wells, T.N.C., Proudfoot, A.E.I., 2001. Chemokine receptors-the next therapeutic target for HIV? Receptors and Channels 7, 417-428.
13. Wollenweber, E., Mann, K., Yatskievych, G., 1986. Epicuticular flavonoid aglycons from leaves of several plants of Mexico and the United States. Bull. Liaison-Groupe Polyphenols 13, 621-623.